Robin Christensen is a senior researcher, biostatistician, and head of the ‘Musculoskeletal Statistics Unit’ at the Parker Institute. He is also an adjunct professor of clinical epidemiology at the Faculty of Health Science, at the University of Southern Denmark.
Professor Christensen did his PhD in evidence-based rheumatology and biostatistics, and works internationally as a statistics (and osteoarthritis) editor for the ’Cochrane Musculoskeletal Group’ (CMSG), as well as being a member of the ’Grading of Recommendations Assessment, Development and Evaluation’ (GRADE) Working Group, the ’Outcome Measures in Rheumatology’ (OMERACT), and the ’International Dermatology Outcome Measures’ (IDEOM) initiatives. Furthermore, he is a member of the BMJ Open’s statistical advisory board and is an editorial member of various journals including ’Arthritis Care & Research’, ’Arthritis Research and Therapy’, and the ‘Cochrane library’. In 2016 Professor Christensen accepted an invitation to join the team of associate editors for ‘Trials’; a journal which encompasses all aspects of the performance and findings of randomised controlled trials in health; Trials encourages full and transparent reporting of all research (EQUATOR network).
Nationally (Denmark), Professor Christensen has been a method consultant for ’The Danish Council for the Use of Expensive Hospital Medicines’ (RADS), and also a guideline panel member on the optimal use of biological agents in rheumatic and dermatological conditions, together with thromboprophylaxis therapy in connection with orthopaedic surgery.
Professor Christensen works with a broad field of biostatistical methods. This field covers a range of clinical epidemiological problems, where inference from meta-epidemiology, study designs, decision making processes, transparency and statistical analysis plans dominate. Stressing the importance of classical statistical methods (incl. transparent reporting of these), he is responsible for the development and analysis of numerous clinical trials and projects, both within and outside of the Parker Institute.
In 2017 Professor Christensen became a founding member of the OMERACT Technical Advisory Group(TAG) for the OMERACT Domain & Instrument Selection Process. The role of the OMERACT TAG is to critically appraise submitted documentation from various Working Groups for adherence to OMERACT filter v. 2.1 checklist requirements.
Professor Christensen is a strong advocate of the REWARD (REduce research Waste And Reward Diligence) Campaign; i.e., focus on how to increase value and reduce waste in biomedical research. Professor Christensen promotes these principles by being a “Lean Thinker”; the core idea is to maximize customer (e.g. patient) value while minimizing waste.
Professor Christensen has published more than 240 peer reviewed articles, including articles in the Lancet, CMAJ, Annals of Internal Medicine, BMJ and JAMA.